Recent studies revealed that inhibition of the CD11b/CD18 could prevent the acute kidney injury and the progression of acute kidney injury to chronic kidney disease (Dehnadi et al., 2017; Yago et al., 2015). Here, ITGB2 is linked to urogenital neoplasm.